Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 août 2024 07h35 HE | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results

IRVINE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for...
13 mai 2024 10h28 HE | Source: Wohl & Fruchter LLP

RPHM Alert: Monsey Firm of Wohl & Fruchter Investigating Proposed Merger of Reneo Pharmaceuticals With OnKure

We are investigating the fairness of the proposed merger of Reneo Pharmaceuticals with OnKure in a stock-for-stock transaction.
13 mai 2024 07h35 HE | Source: Reneo Pharmaceuticals, Inc.; OnKure, Inc

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology Combined company is expected to have...